NEW YORK, June 30, 2023 /PRNewswire/ -- Jakubowitz Law announces that an investigation into potential securities fraud allegations has commenced on behalf of shareholders of Travere Therapeutics, Inc. (NASDAQ: TVTX)

To be contacted by a member of our team, fill out the form:

https://claimyourloss.com/securities/travere-class-action-loss-submission-form/?id=41541&from=4

Further details on the investigation: The investigation focuses on whether Travere issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (628) 895-0423
F: (212) 537-5887

Cision View original content:https://www.prnewswire.com/news-releases/tvtx-fraud-alert-jakubowitz-law-is-investigating-travere-therapeutics-inc-in-connection-with-potential-violations-of-federal-securities-laws-301867198.html

SOURCE Jakubowitz Law

Copyright 2023 PR Newswire

Travere Therapeutics (NASDAQ:TVTX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Travere Therapeutics.
Travere Therapeutics (NASDAQ:TVTX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Travere Therapeutics.